Gil Blum
Stock Analyst at Needham
(2.03)
# 2,822
Out of 4,784 analysts
352
Total ratings
31.75%
Success rate
-5%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STTK Shattuck Labs | Reiterates: Hold | n/a | $1.06 | - | 16 | Mar 27, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $23 | $3.16 | +627.85% | 4 | Mar 25, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.70 | +233.33% | 2 | Mar 19, 2025 | |
| FATE Fate Therapeutics | Reiterates: Hold | n/a | $0.85 | - | 6 | Mar 6, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $84 | $36.99 | +127.09% | 19 | Feb 12, 2025 | |
| CELC Celcuity | Maintains: Buy | $23 → $29 | $10.24 | +183.20% | 13 | Feb 6, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $1.66 | +502.41% | 26 | Jan 13, 2025 | |
| ACLX Arcellx | Reiterates: Buy | $105 | $67.96 | +54.50% | 23 | Dec 10, 2024 | |
| NKTX Nkarta | Reiterates: Buy | $11 | $2.00 | +450.00% | 15 | Mar 27, 2025 | |
| MREO Mereo BioPharma Group | Reiterates: Buy | $7 | $2.30 | +204.35% | 16 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $202 | $70.41 | +186.89% | 29 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.43 | +1,770.03% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $41 | $14.54 | +181.98% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.65 | +203.03% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $29.58 | +140.03% | 13 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $9 | $1.35 | +566.67% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $52 → $42 | $7.59 | +453.36% | 19 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.93 | +210.88% | 25 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $8.43 | - | 6 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $5.81 | +89.33% | 21 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $29 → $28 | $12.15 | +130.45% | 22 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.50 | +701.60% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.84 | +613.18% | 12 | Apr 12, 2024 |
Shattuck Labs
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.06
Upside: -
Artiva Biotherapeutics
Mar 25, 2025
Reiterates: Buy
Price Target: $23
Current: $3.16
Upside: +627.85%
Absci
Mar 19, 2025
Reiterates: Buy
Price Target: $9
Current: $2.70
Upside: +233.33%
Fate Therapeutics
Mar 6, 2025
Reiterates: Hold
Price Target: n/a
Current: $0.85
Upside: -
CRISPR Therapeutics AG
Feb 12, 2025
Reiterates: Buy
Price Target: $84
Current: $36.99
Upside: +127.09%
Celcuity
Feb 6, 2025
Maintains: Buy
Price Target: $23 → $29
Current: $10.24
Upside: +183.20%
Autolus Therapeutics
Jan 13, 2025
Reiterates: Buy
Price Target: $10
Current: $1.66
Upside: +502.41%
Arcellx
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $67.96
Upside: +54.50%
Nkarta
Mar 27, 2025
Reiterates: Buy
Price Target: $11
Current: $2.00
Upside: +450.00%
Mereo BioPharma Group
Mar 26, 2025
Reiterates: Buy
Price Target: $7
Current: $2.30
Upside: +204.35%
Mar 18, 2025
Reiterates: Buy
Price Target: $202
Current: $70.41
Upside: +186.89%
Mar 14, 2025
Reiterates: Buy
Price Target: $8
Current: $0.43
Upside: +1,770.03%
Mar 13, 2025
Reiterates: Buy
Price Target: $41
Current: $14.54
Upside: +181.98%
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.65
Upside: +203.03%
Mar 12, 2025
Reiterates: Buy
Price Target: $71
Current: $29.58
Upside: +140.03%
Mar 5, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.35
Upside: +566.67%
Feb 28, 2025
Maintains: Buy
Price Target: $52 → $42
Current: $7.59
Upside: +453.36%
Feb 27, 2025
Reiterates: Buy
Price Target: $6
Current: $1.93
Upside: +210.88%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $8.43
Upside: -
Feb 6, 2025
Reiterates: Buy
Price Target: $11
Current: $5.81
Upside: +89.33%
Jan 29, 2025
Maintains: Buy
Price Target: $29 → $28
Current: $12.15
Upside: +130.45%
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.50
Upside: +701.60%
Apr 12, 2024
Reiterates: Buy
Price Target: $6
Current: $0.84
Upside: +613.18%